Skip to main content
Egyptian Journal of Medical Human Genetics

Table 8 Correlation of METTL3 gene expression level to blast count during follow-up stages for assessment of early response to chemotherapy and maintenance of CR

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

 

METTL3 gene expression (during follow-up)

R

p value

Assessment of early response to chemotherapy

 Day 28 BM blast %

0.377

0.037*

Assessment of maintenance of CR

 2nd month BM blast %

0.872

< 0.001**

 4th month BM blast %

0.649

0.016*

 6th month BM blast %

0.833

0.002*

  1. * mean statistically significant value (< 0.05) and ** mean highly statistically significant (< 0.001)
Back to article page